Riskpilot← Back to searchSign inGet full accessAtley Solutions AB
ABActiveOrg 5592251010Medicinaregatan 8 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 201910-19 employees
Revenue 2024
SEK 10,4M
+351% vs 2023
EBITDA margin
-75.8%
-90% vs 2023
Equity ratio
79.2%
Financial strength
Net profit 2024
SEK -10,5M
-132% vs 2023
| Revenue | SEK 10,4M | +351% |
| EBITDA | SEK -7,9M | -90% |
| Net profit | SEK -10,5M | -132% |
| Total assets | SEK 41,5M | +57% |
| Equity | SEK 32,9M | +79% |
| Employees | — | — |
Legal name
Atley Solutions AB
Org number
5592251010
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4 november 2019
Share capital
SEK 120 904
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska utveckla och kommersialisera produkter och tjänster för utveckling av radioaktiva läkemedel samt bedriva därmed förenlig verksamhet.
Address
Medicinaregatan 8 B
Email
info@atley.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 20 | 220 | 506 | 2 312 | 10 433 |
| Staff expenses | — | — | — | — | −8 054 |
| EBITDA | −238 | −1 345 | −2 370 | −4 155 | −7 910 |
| Depreciation & amort. | −0 | −36 | −158 | −296 | −2 778 |
| EBIT | −238 | −1 381 | −2 528 | −4 451 | −10 689 |
| Net financials | — | −17 | −248 | −86 | 161 |
| Profit before tax | −238 | −1 398 | −2 775 | −4 537 | — |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −238 | −1 398 | −2 775 | −4 537 | −10 528 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 056 | 8 460 | 27 477 | 26 489 | 41 533 |
| Equity | 7 123 | 5 725 | 22 879 | 18 343 | 32 892 |
| Long-term debt | 409 | 500 | 2 825 | 1 966 | 500 |
| Short-term debt | 524 | 2 235 | 1 773 | 6 179 | 8 141 |
| Total debt | 933 | 2 735 | 4 598 | 8 145 | 8 641 |
EBITDA margin
-75.8%
This company
15.8%
Market median
-580% vs market
20202024
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
20202024
Return on equity
-32.0%
This company
18.4%
Market median
-274% vs market
20202024
Net profit margin
-100.9%
This company
8.1%
Market median
-1346% vs market
20202024
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FP Chief Auditor | Chief Auditor | 2022 | — | — |
EM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Atley Solutions AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Filip Patrik Laurin | Chief Auditor | 0 companies |
| Erik Milton Cromwell Lönnroth | Chief Executive Officer | 0 companies |
| Johanna Kristina Asklin | Board of Directors | 0 companies |
| Erik Anders Mattias Münnich | Deputy Board Member | 0 companies |
| Sture Lindegren | Deputy Board Member | 0 companies |
| Lars Fredrik Bergman | Board of Directors | 0 companies |
| Emma Hilda Kristina Aneheim | Board of Directors | 0 companies |
| Erik Anders Strömqvist | Chairman | 0 companies |
| Jonas Olof Bergman | Board of Directors | 0 companies |